Evidence map›Paper›PMID 41526950›Full record

ArticleInternational journal for equity in health2026

Towards effective coverage of Chagas disease: a community-based approach in migrant populations.

Jordi Gómez I Prat, Paula Fernández-Torres, Isabel Claveria Guiu, Alicia Garcia Circuns, Helena Martinez Alguacil, Estefa Choque, Marina Gold, Aurore Dehousse, Pedro Albajar-Vinas, Francesc Zarzuela and 4 more

Abstract read
In one paragraph

Article in International journal for equity in health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jordi Gómez I Prat *Department of Infectious Diseases, Public Health and Community Team (eSPiC), Drassanes-Vall d'Hebron International Health Unit (USIDVH), Vall d'Hebron University Hospital, Barcelona, Spain. jordi.gomez@vallhebron.cat.
Paula Fernández-Torres *Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Isabel Claveria GuiuDepartment of Infectious Diseases, Public Health and Community Team (eSPiC), Drassanes-Vall d'Hebron International Health Unit (USIDVH), Vall d'Hebron University Hospital, Barcelona, Spain.
Alicia Garcia CircunsDepartment of Infectious Diseases, Public Health and Community Team (eSPiC), Drassanes-Vall d'Hebron International Health Unit (USIDVH), Vall d'Hebron University Hospital, Barcelona, Spain.
Helena Martinez AlguacilDepartament de Salut, Generalitat de Catalunya, Agència de Salut Pública de Catalunya, Barcelona, 08005, Spain.
Estefa ChoqueDepartment of Infectious Diseases, Public Health and Community Team (eSPiC), Drassanes-Vall d'Hebron International Health Unit (USIDVH), Vall d'Hebron University Hospital, Barcelona, Spain.
Marina GoldMundo Sano Foundation, Madrid, Spain.
Aurore DehousseDepartment of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.
Pedro Albajar-VinasDepartment of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.
Francesc ZarzuelaDepartment of Microbiology, Tropical Medicine Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
Elena Sulleiro IgualDepartment of Microbiology, Tropical Medicine Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
Israel Molina RomeroInternational Health Program of the Catalan Institute of Health (PROSICS), Barcelona, Spain.
Jacobo MendiorozDepartament de Salut, Generalitat de Catalunya, Agència de Salut Pública de Catalunya, Barcelona, 08005, Spain.
Hakima Ouaarab EssadekDepartment of Infectious Diseases, Public Health and Community Team (eSPiC), Drassanes-Vall d'Hebron International Health Unit (USIDVH), Vall d'Hebron University Hospital, Barcelona, Spain.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundCommunity-based approaches have proven effective in improving early access to diagnosis for Chagas disease (CD). This study aimed to assess whether such strategies could reduce the number of patients lost to follow-up and contribute to the detection of concomitant Strongyloides stercoralis infection.

methodsThe intervention was implemented at the Consulate General of Bolivia in Barcelona and began with awareness-raising activities about CD. The Public Health and Community team (eSPiC) subsequently offered on-site serological screening for CD, as well as diagnostic confirmation, antiparasitic treatment, and follow-up at the Drassanes-Vall d'Hebron International Health Unit (USIDVH).

resultsOf the 325 participants, 96.3% were adults of Bolivian origin residing in Catalonia, Spain. The mean age was 43 years, and 64.3% were women. Forty-two participants (13.5%) tested positive for CD and received a follow-up appointment. Of these, 22 (52%) attended the consultation; 10 (45.5%) completed antiparasitic treatment; 4 (18.2%) had been previously treated; 2 (9.1%) were not treated due to medical decision; and 6 (27.3%) were lost to follow-up.

conclusionsThis study suggests that community-based follow-up strategies are advisable, particularly among middle-aged women with primary or secondary education. They facilitate a comprehensive continuum of care-from on-site screening to treatment adherence-which is essential for achieving the Chagas disease targets of the World Health Organization's Road Map for Neglected Tropical Diseases by 2030.

Indexed as

Chagas DiseaseCommunity Health ServicesTransients and MigrantsAdultAnimalsAntiparasitic AgentsBoliviaFemaleHumansLost to Follow-UpMaleMiddle AgedSpainStrongyloides stercoralisStrongyloidiasisAntiparasitic AgentsChagas diseaseCommunity-based strategyComprehensive follow-upIn-situ screeningMigrant populationOpportunities of systematic integrationStrongyloidiasis

Identifiers

PMID41526950
PMCPMC12879460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.